Who we areWe are an interdisciplinary team leading a transformative approach to drug R&D based on the modeling of complex biological systems
#drugR&D #insilicomedicine #clinicalresearchmethodology #systemsbiology #machinelearning
François-Henri BOISSEL, MSc
Co-founder & Chief Executive Officer
François-Henri holds an MSc in Management from ESSEC Business School. Prior to founding NOVADISCOVERY, he spent 4 years with the investment bank Lehman Brothers in London and Tokyo where he has developed an expertise in financial engineering, deal structuring & execution. François-Henri has participated in securitization deals across a wide range of assets representing total completed financings in excess of US$ 500 million in Europe and Asia.
As Novadiscovery’s cofounder and CEO since 2010, François-Henri has honed a variety of skills ranging from corporate structuring to business development and people management.